Local News: Central America 

 | 

Sign Up

 | 

Sign In

Advertisment

Neurocrine Biosciences

Neurocrine Biosciences News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Neurocrine Biosciences News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Neurocrine Biosciences News

News on Neurocrine Biosciences continually updated from thousands of sources around the net.

Monday Dec 21 | Medical News

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Neurocrine Biosciences, Inc. today announced their highly selective vesicular monoamine transporter 2 inhibitor, NBI-98854, will be advanced in clinical development.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Dec 18, 2009

San Diego Union-Tribune

CareFusion shareholders advised to spurn buy...

CareFusion said it has learned of an effort to acquire up to 4 million of its shares through a a oemini-tendera offer but is recommending that shareholders turn down the deal.

Comment?

Related Topix: San Diego Metro, Hepatitis, Medicine, Health, Healthcare Industry, Biotech

Fri Dec 11, 2009

San Diego Source

Neurocrine rises on clinical results

Shares of Neurocrine Biosciences Inc. lifted in after-hours trading after the San Diego-based company said its endometriosis treatment proved safe and effective in its fifth Phase 2 clinical trial.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, San Diego Metro, Endometriosis, Health

Thu Dec 10, 2009

Drugs.com

Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL...

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study , its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone receptor antagonist, elagolix, in patients with endometriosis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Endometriosis, Health

Wed Nov 25, 2009

American Chronicle

News and FDA Updates for ImmunoGen

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, ImmunoGen, Healthcare Industry, Restaurant Management, Garden Fresh Restaurant, Opinion

Thu Oct 29, 2009

The Biotech Stock Blog

Neurocrine Biosciences, Inc. Q3 2009 Earnings Conference Call

Neurocrine Biosciences, Inc. October 29, 2009 08:30 a.m. ET Executives Kevin Gorman - President and CEO Jane Sorensen - IR Tim Coughlin - VP and CFO Analysts Brian Abrahams - Oppenheimer & Company Craig Gordon - Cowen and Company Presentation Operator Good day everyone and welcome to today's program.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

PR-inside.com

Neurocrine Biosciences Inc.-Deals & Alliances Report - research report released

The report also includes M&A statistics and recent partnering news updates by date.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

Fri Oct 23, 2009

Freshnews

Neurocrine Biosciences Announces Conference Call and Webcast to...

Neurocrine Biosciences, Inc. announced today that the Company will report its third quarter 2009 financial results after the Nasdaq market closes on Wednesday, October 28, 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Sat Sep 19, 2009

American Chronicle

Updates Micromet

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Biotech, Micromet, Healthcare Law, Law, Food and Drug Administration, Medicine, Healthcare Industry, Computers, icad, Medical Equipment, Oncology, Opinion

Thu Sep 17, 2009

BioWorld

Neurocrine Snares $75M CEFF to Hunt for Products to License

Neurocrine Biosciences Inc. has secured a commitment from Kingsbridge Capital Ltd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law

Wed Sep 16, 2009

BioSpace

Neurocrine Biosciences, Inc. Gets Funding of up to $75 Million

Neurocrine Biosciences, Inc. announced today that the Company has entered into a Committed Equity Financing Facility with Kingsbridge Capital Limited, a private investment group.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

The San Diego Union-Tribune

Neurocrine Biosciences selling stock to group

Neurocrine Biosciences announced an agreement under which private investment group Kingsbridge Capital will buy up to $75 million worth of newly issued Neurocrine stock over the next three years.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, San Diego Metro, US Military, US Navy, Science / Technology

Thu Jul 30, 2009

The Biotech Stock Blog

Neurocrine Biosciences, Inc. Q2 2009 Earnings Call Transcript

Neurocrine Biosciences, Inc. July 30, 2009 8:30 am ET Executives Kevin Gorman - President and CEO Jane Sorensen - IR Tim Coughlin - VP and CFO Analysts Brian Abrahams - Oppenheimer & Company Phil Nadeau - Cowen & Company Tommy Nuane [ph] - Piper Jaffray Larry Smith - DLS Research Presentation Operator Good morning and welcome to Neurocrine ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jul 27, 2009

Freshnews

Webcast Alert: Neurocrine Biosciences Announces 2nd Quarter 2009 Earnings Results

Companies mentioned in this article: Neurocrine Biosciences, Inc. SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Neurocrine Biosciences announces the following Webcast: What: Neurocrine Biosciences Webcast When: July 30, 2009 @ 8:30am EDT Where: http://www.videonewswire.com/event.asp?id=60921 How: Live over the Internet -- Simply log on to the web at ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Jul 23, 2009

M2.com

SDTH, IVAC, FLDR, NBIX, HYC, OPXT Expected To Be Lower Leading Up To Next Earnings Releases

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July/August earnings reports.

Comment?

Related Topix: Financial Markets, Intevac, Scientific Instruments, Electronics, Computers, Startups, Manufacturing, Industrial Machines, Flanders, Hypercom, Biotech, Medicine, Healthcare Industry

Mon Jul 20, 2009

Customer Interaction Solutions

BUYINS.NET: SNIC, NBIX, RDNT, QADI, NMRX, ABTL Expected To Be Lower...

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July/August earnings reports.

Comment?

Related Topix: Financial Markets, Sonic Solutions, Computers, Software, Startups, Biotech, Medicine, Healthcare Industry, RadNet, QAD

Fri Jun 19, 2009

Zacks Analyst Blog

NBIX's Elagolix Moving Forward

NBIX's Elagolix Moving Forward By: Jason Napodano, CFA 2 ) Share Just recently, Neurocrine Bio presented results from the full twelve month analysis of the Petal-603 study, which includes data from the six months on treatment and six months follow-up period.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Endometriosis, Health, Healthcare Law, Law

Wed Jun 17, 2009

M2.com

Neurocrine Biosciences presents data from Phase I, Phase II elagolix trials

The first clinical abstract presentation reviews the results of a Phase I study in which elagolix was evaluated over six weeks in 60 healthy premenopausal women.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Also on Topix